The L-arginine nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man

被引:48
作者
Newby, DE
Wright, RA
Dawson, P
Ludlam, CA
Boon, NA
Fox, KAA
Webb, DJ
机构
[1] Univ Edinburgh, Western Gen Hosp, Clin Pharmacol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Edinburgh, Western Gen Hosp, Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Univ Edinburgh, Royal Infirm, Dept Cardiol, Edinburgh EH3 9YW, Midlothian, Scotland
[4] Univ Edinburgh, Royal Infirm, Dept Haematol, Edinburgh EH3 9YW, Midlothian, Scotland
关键词
thrombolysis; endothelial factor; nitric oxide; blood flow; endothelial function;
D O I
10.1016/S0008-6363(98)00017-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Effective endogenous fibrinolysis requires rapid release of endothelial tissue plasminogen activator (t-PA). Using the nitric oxide synthase inhibitor, L-N-G-monomethylarginine (L-NMMA), we examined the contribution of endogenous nitric oxide to substance P-induced t-PA release in vivo in man, Methods: Blood flow and plasma fibrinolytic and haemostatic factors were measured in both forearms of 8 healthy male volunteers who received unilateral brachial artery infusions of substance P (2-8 pmol/min) and L-NMMA (1-4 mu g/min). Results: Substance P caused dose-dependent increases in blood flow (P < 0.001) and plasma t-PA antigen (P = 0.04) and activity (P < 0.001) concentrations confined to the infused forearm, but had no effect on plasminogen activator inhibitor type 1 (PAI-1) or von Willebrand factor concentrations. In the presence of L-NMMA, substance P again caused significant increases in blood flow (P < 0.001) and t-PA antigen (P = 0.003) and activity (P < 0.001) concentrations but these increases were significantly less than with substance P alone(P < 0.001, P = 0.05 and P < 0.01, respectively). L-NMMA alone significantly reduced blood flow in the infused arm, but had no measurable effect on t-PA or PAI-I concentrations. Conclusions: The L-arginine/nitric oxide pathway contributes to substance P-induced t-PA release in vivo in man. This provides an important potential mechanism whereby endothelial dysfunction increases the risk of atherothrombosis through a reduction in the acute fibrinolytic capacity. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 45 条
[1]   CIRCADIAN VARIATION OF FIBRINOLYTIC-ACTIVITY IN BLOOD [J].
ANDREOTTI, F ;
KLUFT, C .
CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (05) :336-351
[2]   TISSUE PLASMINOGEN-ACTIVATOR - TORONTO (TPAT) PLACEBO-CONTROLLED RANDOMIZED TRIAL IN ACUTE MYOCARDIAL-INFARCTION [J].
ARMSTRONG, PW ;
BAIGRIE, RS ;
DALY, PA ;
HAQ, A ;
GENT, M ;
ROBERTS, RS ;
FREEMAN, MR ;
BURNS, R ;
LIU, P ;
MORGAN, CD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (07) :1469-1476
[3]   MEASURING FOREARM BLOOD-FLOW AND INTERPRETING THE RESPONSES TO DRUGS AND MEDIATORS [J].
BENJAMIN, N ;
CALVER, A ;
COLLIER, J ;
ROBINSON, B ;
VALLANCE, P ;
WEBB, D .
HYPERTENSION, 1995, 25 (05) :918-923
[4]  
BOOTH NA, 1987, BLOOD, V69, P1600
[5]   DIRECT OBSERVATION OF SUBSTANCE-P-INDUCED INTERNALIZATION OF NEUROKININ-1 (NK1) RECEPTORS AT SITES OF INFLAMMATION [J].
BOWDEN, JJ ;
GARLAND, AM ;
BALUK, P ;
LEFEVRE, P ;
GRADY, EF ;
VIGNA, SR ;
BUNNETT, NW ;
MCDONALD, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8964-8968
[7]   IMPAIRED ENDOTHELIUM-DEPENDENT VASCULAR RELAXATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA EXTENDS BEYOND THE MUSCARINIC RECEPTOR [J].
CASINO, PR ;
KILCOYNE, CM ;
CANNON, RO ;
QUYYUMI, AA ;
PANZA, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (01) :40-44
[8]   IMPAIRED RELEASE OF TISSUE PLASMINOGEN-ACTIVATOR (T-PA) FOLLOWING DDAVP INFUSION IN VONWILLEBRANDS DISEASE WITH LOW PLATELET VONWILLEBRAND-FACTOR CONTENT [J].
CASONATO, A ;
SARTORI, MT ;
PONTARA, E ;
ZUCCHETTO, A ;
DANNHAUSER, D ;
PATRASSI, G ;
GIROLAMI, A .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (02) :149-153
[9]  
CEJKA J, 1982, CLIN CHEM, V28, P1356
[10]   Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults [J].
Celermajer, DS ;
Adams, MR ;
Clarkson, P ;
Robinson, J ;
McCredie, R ;
Donald, A ;
Deanfield, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :150-154